1-20 of 29
Authors: Patrick Healy
Journal Article
CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi51, https://doi.org/10.1093/neuonc/noab196.202
Published: 12 November 2021
Journal Article
EPCT-13. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii306, https://doi.org/10.1093/neuonc/noaa222.136
Published: 04 December 2020
Journal Article
ATIM-31. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi8, https://doi.org/10.1093/neuonc/noz175.030
Published: 11 November 2019
Journal Article
HOUT-21. CHARACTERISTICS OF SHORT-TERM SURVIVAL IN PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE ANALYSIS Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi116, https://doi.org/10.1093/neuonc/noz175.486
Published: 11 November 2019
Journal Article
INNV-18. THE AVAILABILITY AND ROLE OF CLINICAL PHARMACISTS IN THE AMBULATORY NEURO-ONCOLOGY SETTING: AN INTERNATIONAL SURVEY Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi134, https://doi.org/10.1093/neuonc/noz175.561
Published: 11 November 2019
Journal Article
ATIM-24. DOSE FINDING AND DOSE EXPANSION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi6, https://doi.org/10.1093/neuonc/noz175.023
Published: 11 November 2019
Journal Article
ACTR-28. PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi17, https://doi.org/10.1093/neuonc/noy148.061
Published: 05 November 2018
Journal Article
RARE-16. CLINICAL AND HISTOPATHOLOGICAL CHARACTERISTICS OF YOUNG ADULTS WITH GLIOBLASTOMA AT DIAGNOSIS Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi239, https://doi.org/10.1093/neuonc/noy148.990
Published: 05 November 2018
Journal Article
QOLP-17. REVIEW AND META-ANALYSIS OF NAUSEA AND VOMITING TRIALS FOR MALIGNANT GLIOMAS Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi218, https://doi.org/10.1093/neuonc/noy148.903
Published: 05 November 2018
Journal Article
ATIM-36. DOSE ESCALATION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi9, https://doi.org/10.1093/neuonc/noy148.031
Published: 05 November 2018
Journal Article
QLIF-05. A SINGLE INSTITUTION’S EXPERIENCE EXPLORING THE ASSOCIATION OF INTEGRATIVE MEDICINE AND SURVIVORSHIP IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi202, https://doi.org/10.1093/neuonc/nox168.816
Published: 06 November 2017
Journal Article
QLIF-22. MAINTENANCE OF HEALTH RELATED QUALITY OF LIFE (QOL) BEYOND PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi206, https://doi.org/10.1093/neuonc/nox168.832
Published: 06 November 2017
Journal Article
QLIF-34. PILOT STUDY TO DESCRIBE THE TRAJECTORY OF SYMPTOMS AND ADAPTIVE STRATEGIES OF ADULTS LIVING WITH LOW GRADE GLIOMAS (LGG) Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi208–vi209, https://doi.org/10.1093/neuonc/nox168.843
Published: 06 November 2017
Journal Article
RARE-36. PATTERNS OF RELAPSE AFTER SUCCESSFUL COMPLETION OF INITIAL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi217, https://doi.org/10.1093/neuonc/nox168.878
Published: 06 November 2017
Journal Article
PALL-02. PERAMPANEL FOR TREATMENT OF REFRACTORY SEIZURES IN PATIENTS WITH GLIOMAS Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi168, https://doi.org/10.1093/neuonc/nox168.684
Published: 06 November 2017
Journal Article
PALL-10. INCREASED FATIGUE ASSOCIATED WITH TUMOR PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi170, https://doi.org/10.1093/neuonc/nox168.691
Published: 06 November 2017
Journal Article
ATIM-18. PHASE I DOSE ESCALATION STUDY OF D2C7-IT ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi21–vi22, https://doi.org/10.1093/neuonc/now212.083
Published: 07 November 2016
Journal Article
QLIF-20. A CROSS-SECTIONAL STUDY OF DISTRESS THROUGHOUT THE DISEASE TRAJECTORY IN PRIMARY BRAIN TUMOR PATIENTS Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi160, https://doi.org/10.1093/neuonc/now212.664
Published: 07 November 2016
Journal Article
IMCT-19COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v111–v112, https://doi.org/10.1093/neuonc/nov218.19
Published: 09 November 2015
Journal Article
ATCT-13BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION: A PHASE II TRIAL Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v4, https://doi.org/10.1093/neuonc/nov206.13
Published: 09 November 2015
